[O-11] Oral Session 11

[O-11-5] Investigation of immune response to JCV in MS patients taking fingolimod (an interim analysis)

Hiroyuki Toda¹, Toyokazu Saiki², Jun-ichi Kira^3,4 (1.Novartis Pharma K.K. Medical Affairs Division, Japan, 2.Mitsubishi Tanabe Pharma Corporation, Japan, 3.International University of Health and Welfare, Japan, 4.Brain and Nerve Center, Fukuoka Central Hospital, Japan)